Your session is about to expire
← Back to Search
FSD201 for Mast Cell Activation Syndrome
Study Summary
This trial will study if a drug can reduce pain intensity in adults with chronic muscle and joint pain.
- Mast Cell Activation Syndrome
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are individuals who are twenty years of age or older eligible to participate in this trial?
"This research project is inviting adults aged between 18 and 75 to take part in the trial."
Has FSD201 been validated by the FDA?
"Considering the fact that this is a Phase 2 clinical trial, which means there is evidence of safety but not efficacy, our team assigned FSD201 a score of 2 on a scale from 1 to 3."
Is this research endeavor inviting participants to sign up?
"Clinicaltrials.gov reflects that this medical trial, which was made available on December 1st 2022 and lastly updated on the 8th of December, is no longer in need of participants. Fortunately, there are an abundance of other clinical trials actively recruiting patients currently."
Is it feasible for me to enroll in this experiment?
"This medical trial is open to individuals between 18-75 years old who are diagnosed with mast cell activation syndrome. The maximum number of patients accepted into the study will be 60."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger